These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6823373)

  • 1. Clinical significance of estrogen and progestin receptors in ovarian cancer.
    Kauppila A; Vierikko P; Kivinen S; Stenbäck F; Vihko R
    Obstet Gynecol; 1983 Mar; 61(3):320-6. PubMed ID: 6823373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are cytosol estrogen and progestin receptors of prognostic significance in the management of epithelial ovarian cancers?
    Schwartz PE; MacLusky N; Merino MJ; Livolsi VA; Kohorn EI; Eisenfeld A
    Obstet Gynecol; 1986 Dec; 68(6):751-8. PubMed ID: 3785785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
    Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
    Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathologic correlations of estrogen and progestin receptor protein in epithelial ovarian carcinomas.
    Schwartz PE; Merino MJ; Livolsi VA; Lawrence R; MacLusky N; Eisenfeld A
    Obstet Gynecol; 1985 Sep; 66(3):428-33. PubMed ID: 4022502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytoplasmatic receptors of steroid hormones in malignant epithelial ovarian tumors].
    Makhova EE; Gershteĭn ES; Smirnova KD; Murav'eva NI; Kuz'mina ZV
    Vopr Onkol; 1984; 30(12):36-40. PubMed ID: 6516272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of estrogen and progesterone receptors in epithelial ovarian cancer.
    Rose PG; Reale FR; Longcope C; Hunter RE
    Obstet Gynecol; 1990 Aug; 76(2):258-63. PubMed ID: 2371031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients.
    Fischer-Colbrie J; Witt A; Heinzl H; Speiser P; Czerwenka K; Sevelda P; Zeillinger R
    Anticancer Res; 1997; 17(1B):613-9. PubMed ID: 9066588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen.
    Langdon SP; Gabra H; Bartlett JM; Rabiaz GJ; Hawkins RA; Tesdale AL; Ritchie AA; Miller WR; Smyth JF
    Clin Cancer Res; 1998 Sep; 4(9):2245-51. PubMed ID: 9748145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptors in ovarian epithelial carcinoma.
    Schwartz PE; LiVolsi VA; Hildreth N; MacLusky NJ; Naftolin FN; Eisenfeld AJ
    Obstet Gynecol; 1982 Feb; 59(2):229-38. PubMed ID: 7078869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and progestin receptors in an ovarian ependymoma.
    Auerbach R; Mittal K; Schwartz PE
    Obstet Gynecol; 1988 Jun; 71(6 Pt 2):1043-5. PubMed ID: 2836769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid receptors in epithelial ovarian carcinoma: relation to clinical parameters and survival.
    Bizzi A; Codegoni AM; Landoni F; Marelli G; Marsoni S; Spina AM; Torri W; Mangioni C
    Cancer Res; 1988 Nov; 48(21):6222-6. PubMed ID: 3167868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertoliform endometrioid carcinomas of the ovary: a clinicopathologic and immunohistochemical study of 13 cases.
    Ordi J; Schammel DP; Rasekh L; Tavassoli FA
    Mod Pathol; 1999 Oct; 12(10):933-40. PubMed ID: 10530556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and progesterone receptors in uterine sarcomas.
    Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE
    Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estrogen and progesterone receptors in malignant ovarian neoplasms].
    Teufel G; Geyer H; de Gregorio G; Fuchs A; Kleine W; Pfleiderer A
    Geburtshilfe Frauenheilkd; 1983 Dec; 43(12):732-40. PubMed ID: 6559148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence and distribution of estrogen receptor in advanced epithelial ovarian carcinoma after chemotherapy.
    Richman CM; Holt JA; Lorincz MA; Herbst AL
    Obstet Gynecol; 1985 Feb; 65(2):257-63. PubMed ID: 3969239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in non-diseased tissue and in benign and malignant tumors of the human ovary.
    Vierikko P; Kauppila A; Vihko R
    Int J Cancer; 1983 Oct; 32(4):413-22. PubMed ID: 6311758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple parameter analyses of human ovarian cancer: morphology, immunohistochemistry, steroid hormone receptors and aromatase.
    Kühnel R; Rao BR; Poels LG; Delemarre JF; Kenemans P; Stolk JG
    Anticancer Res; 1988; 8(2):281-6. PubMed ID: 3364939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor.
    Kieback DG; McCamant SK; Press MF; Atkinson EN; Gallager HS; Edwards CL; Hajek RA; Jones LA
    Cancer Res; 1993 Nov; 53(21):5188-92. PubMed ID: 8221656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.